...
首页> 外文期刊>癌と化学療法 >A case of aged advanced breast cancer with multiple lung and pleural metastases responding to exemestane monotherapy
【24h】

A case of aged advanced breast cancer with multiple lung and pleural metastases responding to exemestane monotherapy

机译:具有多种肺和胸膜转移的老年晚期乳腺癌的案例,响应大使单药治疗

获取原文
获取原文并翻译 | 示例

摘要

A 76-year-old woman was diagnosed with advanced breast cancer with bilateral multiple lung and pleural metastases in March 2003. Her CEA and CA15-3 level were 7.6 ng/ml and 98.3 U/l, respectively. However, she refused intensive chemotherapy and chose a hormonal monotherapy with exemestane instead. The patient then did not return to our department for about one year, during which time she continued to take the same medications. When she visited again, CEA and CA15-3 level were reduced to within the normal range, and her multiple lung and pleural metastases were found to have almost completely disappeared upon computed tomography. Exemestane is expected to be an effective agent for the treatment of hormonal receptor-positive postmenopausal woman with life-threatening advanced breast cancer.
机译:2003年3月,一名76岁的女性被诊断为具有双侧多肺和胸膜转移的先进乳腺癌。她的CEA和CA15-3水平分别为7.6ng / ml和98.3u / l。 然而,她拒绝了强化化疗,并选择了一种荷尔蒙单疗法,而是反而。 然后患者没有回到我们的部门大约一年,在此期间她继续服用相同的药物。 当她再次访问时,CEA和CA15-3水平降低到正常范围内,并且发现她的多种肺和胸膜转移在计算断层扫描时几乎完全消失。 预计Exemestane将成为治疗致荷敏性患者患有危及生命的晚期乳腺癌的有效剂的药剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号